Welcome to PsychU!
Improving Mental Health Care... Together

Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

National April 15 6:30 pm to 7:45 pm EDT
  1. Home
  2. Events
  3. Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

The presenters will discuss the history of psychedelics in therapeutic approaches with a primary focus on psilocybin. They will also review the neurobiology of psychedelics and the role of 5-HT2A receptors, review the results of recently published findings, and discuss the challenges associated with psychedelic-assisted therapies.

Featuring

  • Philip G. Janicak, MD

    Adjunct Professor and Consultant to the Therapeutic Neuromodulation Program in the Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine and a Distinguished Life Fellow in the American Psychiatric Association

  • Rachel Self, PhD, MS (OPDC)

    Clinical & Scientific Director

Philip G. Janicak, MD is a consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. Rachel Self, PhD, MS is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.rn

Related Events

Register

This event registration is closed.

Stay Connected: